Pharmaceutical Industry Information Portal

HomeTagsBristol Myers Squibb

All posts by tag

Bristol Myers Squibb

Bristol Myers must face $6.4 bln lawsuit over delayed cancer drug

A U.S. judge on Friday refused to dismiss a $6.4 billion lawsuit accusing Bristol Myers Squibb Co of delaying its Breyanzi cancer drug to...

Bristol Myers Squibb announces a $4.1 billion deal to acquire Turning Point Therapeutics

Pharmaceutical giant Bristol Myers Squibb Company announced a $4.1 billion deal for Turning Point Therapeutics Inc  on Friday morning, the first sizable acquisition for...

BMS, Merck enter into $2.3 billion partnership with Amphista to discover and develop small molecule protein degraders

Amphista Therapeutics, a global leader in the discovery and development of next generation targeted protein degradation (TPD) therapeutics, May 4th announced a strategic collaboration...

Bristol Myers Squibb sales grew in Q1 due to growth in line products

Pharmaceutical company, drug maker Bristol Myers Squibb on Friday posted slightly higher-than-expected first-quarter earnings thanks to increased sales of its blood-thinning drug Eliquis and...

Nektar Therapeutics and Bristol Myers Squibb stop clinical trials for key cancer drug

Nektar Therapeutics and Bristol Myers Squibb announced that based on results from pre-planned analyses of two late-stage clinical studies of bempegaldesleukin (BEMPEG) in combination...

FDA approves Bristol Myers’ Opdualag cancer immunotherapy

Bristol Myers Squibb announced that OpdualagTM, a new, first-in-class, fixed-dose combination of nivolumab and relatlimab, administered as a single intravenous infusion, was approved by...
spot_img

Expert Articles

spot_img